Literature DB >> 19201652

T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response.

Michail V Sitkovsky1.   

Abstract

T regulatory cells (Treg cells) suppress immune responses to maintain self tolerance, but they also protect cancerous tissues. I propose a model to potentially unify the diverse functions of Treg cells. This assumes that Treg cells provide a complementary immunological arm to a physiological tissue-protecting mechanism, driven by low oxygen tension (i.e. hypoxia) in inflamed or cancerous tissues. The cAMP-elevating A2A and A2B adenosine receptors, hypoxia inducible transcription factor 1alpha (HIF), the cAMP response element (CRE)- and hypoxia response element (HRE)-mediated transcription in Treg and effector cells have key roles in this model. Both the T cell receptor (TCR)-triggered- and HRE- and CRE-driven activities of Treg cells are required to achieve a maximal level of immune suppression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201652     DOI: 10.1016/j.it.2008.12.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  93 in total

1.  T-cell tolerance: central and peripheral.

Authors:  Yan Xing; Kristin A Hogquist
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

Review 2.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

3.  Can respiratory hyperoxia mitigate adenosine-driven suppression of antitumor immunity?

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Ann Transl Med       Date:  2015-11

4.  Something in the air: hyperoxic conditioning of the tumor microenvironment for enhanced immunotherapy.

Authors:  Robert D Leone; Maureen R Horton; Jonathan D Powell
Journal:  Cancer Cell       Date:  2015-04-13       Impact factor: 31.743

Review 5.  A(2B) adenosine receptors in immunity and inflammation.

Authors:  György Haskó; Balázs Csóka; Zoltán H Németh; E Sylvester Vizi; Pál Pacher
Journal:  Trends Immunol       Date:  2009-05-07       Impact factor: 16.687

6.  Design and evaluation of xanthine based adenosine receptor antagonists: potential hypoxia targeted immunotherapies.

Authors:  Rhiannon Thomas; Joslynn Lee; Vincent Chevalier; Sara Sadler; Kaisa Selesniemi; Stephen Hatfield; Michail Sitkovsky; Mary Jo Ondrechen; Graham B Jones
Journal:  Bioorg Med Chem       Date:  2013-09-28       Impact factor: 3.641

7.  Methotrexate up-regulates ecto-5'-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment.

Authors:  Fabrício Figueiró; Catiúscia P de Oliveira; Letícia S Bergamin; Liliana Rockenbach; Franciane B Mendes; Elisa Helena F Jandrey; Cesar Eduardo J Moritz; Letícia F Pettenuzzo; Jean Sévigny; Silvia S Guterres; Adriana R Pohlmann; Ana Maria O Battastini
Journal:  Purinergic Signal       Date:  2016-02-24       Impact factor: 3.765

Review 8.  Tissue metabolism and the inflammatory bowel diseases.

Authors:  Jordi M Lanis; Daniel J Kao; Erica E Alexeev; Sean P Colgan
Journal:  J Mol Med (Berl)       Date:  2017-05-20       Impact factor: 4.599

9.  The aptamer-siRNA conjugates: reprogramming T cells for cancer therapy.

Authors:  Dewan Md Sakib Hossain; Priyanka Duttagupta; Marcin Kortylewski
Journal:  Ther Deliv       Date:  2015-01

Review 10.  Induced regulatory T cells in inhibitory microenvironments created by cancer.

Authors:  Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2014-06-17       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.